{
    "nctId": "NCT03063931",
    "briefTitle": "Pain and Magnesium",
    "officialTitle": "Effect of the Oral Route of Magnesium on Pre and Post-mastectomy on the Post-surgery Pain",
    "overallStatus": "UNKNOWN",
    "conditions": "Neuropathic Pain Induced by Mastectomy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Measure of average pain intensity by a numerical rating scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* - Age \u2265 18 years,\n* Patient with breast cancer who has a scheduled total mastectomy with or without treatment two weeks after inclusion with or without preoperative chemotherapy,\n* Patient free from any new treatment or diet at the time of the inclusion,\n* Cooperation and understanding sufficient to comply with the requirements of the study,\n* Patients affiliated to the French Social Security,\n* Patients with free and informed consent has been obtained\n\nExclusion Criteria:\n\n* Hypersensitivity to the active substance or to any of the excipients\n* Patient with magnesemia \\>1,05 mmol/l\n* Patient with severe renal insufficiency with creatinine clearance \\<30 ml min,\n* Patient with an addiction to alcohol, as determined by the investigator,\n* Diabetes (type I and II),\n* Medical and surgical history incompatible with the study,\n* Patient receiving treatment with Quinidine, L-Dopa,\n* Childbearing age, no use of effective contraceptive method, pregnancy or lactation\n* Patient exclusion period, or the total allowable compensation exceeded\n* Patients undergoing a measure of legal protection (guardianship, supervision ...)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}